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Abstract 
The aim of this retrospective chart review study 
was to evaluate the clinical usefulness of an 
ultrasound performed at the intrauterine device 
(IUD) post insertion visit in an otherwise 
asymptomatic patient. The data demonstrated 
that 18% of asymptomatic patients required an 
IUD removal based on an IUD post insertion 
ultrasound 4-8 weeks after insertion. This study 
does support the routine use of performing an 
ultrasound at the IUD post insertion visit in an 
otherwise asymptomatic patient. 
1Northwest Community Hospital, 800 West 
Central Road, Arlington Heights, IL 60005 
Introduction 
Clinical effectiveness, a favorable safety 
profile, and ease of placement in the 
outpatient setting have all contributed to 
an increased use and importance of the 
intrauterine device (IUD) for indications 
of contraception and heavy menstrual 
bleeding over the past decade.1 
In addition to causing post insertion 
symptoms of pain, bleeding, or 
abnormal vaginal discharge, an 
expulsed, displaced, or malpositioned 
IUD may have reduced clinical efficacy 
for contraception or relief of heavy 
uterine bleeding. Such issues may affect 
patient satisfaction or continuation of 
IUD use.2 
It has been suggested that the highest 
risk of downward migration or 
spontaneous expulsion of an IUD may 
occur in the first month of use.3 
For those reasons, an IUD post insertion 
office visit is routinely recommended 4-6 
weeks after successful IUD placement. 
Patient symptoms and a clinical exam 
are often performed at that visit to 
ascertain any post insertion problems or 
complications from IUD insertion. 
The routine use of 2-D and 3-D 
ultrasound at the IUD post insertion visit 
has been advocated by some4, but not 
supported by others.5 
The aim of this retrospective chart 
review study was to evaluate the clinical 
usefulness of an ultrasound performed 
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at the IUD post insertion visit in an 
otherwise asymptomatic patient. 
Materials and Methods 
Institutional Review Board approval 
(Northwest Community Hospital 18-09) 
was obtained for this retrospective chart 
review study. An electronic medical 
record data list was compiled from all 
IUD insertions in our outpatient 
gynecology clinic from January 1, 2014 
to July 27, 2018. 
Pre-insertion data obtained included 
patient characteristics of age, parity, and 
indications for IUD placement. 
Postpartum IUD insertion was noted if 
placed within 12 weeks of delivery with 
the mode of delivery recorded. 
IUD brand type and any intervening 
office visits prior to the scheduled 4-6 
weeks IUD post insertion visit for IUD 
insertion related problems such as 
expulsion, pain, bleeding, or abnormal 
discharge after insertion were reviewed.  
The 4-6 weeks IUD post insertion office 
visit data was reviewed for post insertion 
symptoms of pain, bleeding, IUD 
expulsion or other IUD related problems 
since the time of placement. When 
performed, ultrasound findings at this 
visit were also reviewed. An IUD post 
insertion transvaginal ultrasound (2-D 
and 3-D) is routinely scheduled 4-6 
weeks after IUD placement. 
For the purposes of this study, 
asymptomatic patients after IUD 
insertion were defined as those patients 
who reported no pain or bleeding 
greater than 1 week after IUD insertion, 
expulsion or removal of the IUD prior to 
the 4-6 weeks IUD post insertion visit, 
had no intervening office visit for an IUD 
related problem prior to the scheduled 
4-6 weeks IUD post insertion visit, and 
had an ultrasound (2-D and 3-D) 
performed at the scheduled IUD post 
insertion visit. 
Ultrasound findings were defined as 
within the endometrium and both arms 
open (normal position), or as abnormal if 
within the endometrial cavity with one or 
both arms not deployed, one or both 
arms embedded within the myometrium, 
IUD located in the lower uterine 
segment, IUD located near the cervical 
tip, lower shaft of IUD in fundal location, 
or clockwise/counterclockwise rotation 
with a lower uterine IUD location, or a 
combination of those findings within a 
single patient. Expulsions, uterine 
perforations, or extra uterine IUD 
locations were also identified if present. 
All IUD’s were placed by experienced 
MD providers in an outpatient office 
setting, with the exception of 1 IUD 
placed under IV sedation in the 
outpatient surgical center. 2-D and 3-D 
follow up ultrasound examinations were 
performed by experienced ultrasound 
technicians with MD provider review. 
Results 
A total of two hundred eighteen patient 
charts with IUD insertion were identified 
during the fifty five month study period. 
Of these, one hundred and forty seven 
(67%) had sufficient data for this 
retrospective review. 
Sixty three (43%) of the one hundred 
and forty seven were symptomatic after 
IUD insertion. Eighty four (57%) were 
asymptomatic at the IUD post insertion 
visit. 
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The mean age of symptomatic patients 
was 31.9 years (range 15-43). 
Seventeen (27%) were nulliparous and 
forty-six (73%) were of single or greater 
parity. Twenty-five (40%) were 
postpartum IUD insertions, of which 
eighteen (29%) were after vaginal 
delivery, four (6%) were after primary C-
section, and two (3%) were via repeat 
C-section. 
Indications for IUD use among the 
symptomatic patients were: 
contraception (n=55), menorrhagia 
(n=5), dysmenorrhea (n=1), and more 
than one indication for IUD use 
(n=2).Two patients had more than one 
indication for IUD use. 
IUD brand types of the symptomatic 
patients included Mirena (n=31), 
Paragard (n=7), Liletta (n=16), Kyleena 
(n=6), and Skyla (n=3). 
Fifty (79%) of the symptomatic patients 
did not require IUD removal. Thirteen 
(21%) of these patients required 
removal: twelve (19%) due to abnormal 
IUD positioning noted on follow up 
ultrasound examination and in one 
(1.5%) symptomatic patient with 
persistent IUD post insertion pain. No 
complete expulsions, uterine 
perforations, or pregnancies were noted 
in the symptomatic group. 
Eighty-four (57%) of the 147 patient 
charts reviewed met the criteria for 
being asymptomatic after IUD insertion. 
The mean age of the asymptomatic 
patients was 33.0 years (range 21-49). 
Nineteen (23%) were nulliparous and 
sixty five (77%) were of one or more 
parity. Twenty-five (30%) of the 
asymptomatic patients were postpartum 
IUD insertions of which twelve (14%) 
were via vaginal delivery, five (6%) via 
primary C-section, and eight (9.5%) 
were by repeat C-section. 
Indications for IUD use in the 
asymptomatic patients were 
contraception (n=73), menorrhagia 
(n=10), and dysmenorrhea (n=1). IUD 
brand types included: Mirena (n=33), 
Paragard (n=33), Liletta (n=12), Kyleena 
(n=4), and Skyla (n=2). 
Of the eighty-four asymptomatic 
patients, twenty-three (27%) had 
abnormal ultrasound findings related to 
abnormal IUD location. Two (2%) 
patients had a bicornuate uterus and 
two (2%) patients had an arcuate uterus 
within this asymptomatic subgroup. 
Fifteen (18%) of the asymptomatic 
patients required removal of the IUD 
based on the subsequent IUD post 
insertion visit ultrasound findings. The 
average IUD post insertion visit was 5.5 
weeks (range 4-8 weeks) for the 
asymptomatic group. 
There were no expulsions, no 
perforations, and no pregnancies 
identified in any of the eighty four 
asymptomatic patients at the IUD post 
insertion visit. 
Characteristics and outcomes of the 
symptomatic and asymptomatic patients 
are summarized in Table 1. 
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Table 1. Characteristics of outcomes of symptomatic and asymptomatic patients 
after IUD insertion 
 Symptomatic (n=63) Asymptomatic(n=84) 
Age (years) 31.9 (range: 15-43) 33.0 (range: 21-49) 
Nulliparous 17 (27%) 19 (23%) 
Parous 46 (73%) 65 (77%) 
Postpartum insertion 25 (40%) 25 (30%) 
        NSVD 18 (29%) 12 (14%) 
       Primary C-section 4 (06%) 5 (06%) 
       Repeat C-section 2 (03%) 8 (9.5%) 
   
Indications   
      Contraception 55 (87%) 73 (87%) 
      Menorrhagia 5 (08%) 10 (12%) 
      Dysmenorrhea 1 (1.5%) 1 (01%) 
     Two indications 2 (03%) —— 
   
IUD Brand Type   
     Mirena 31 (49%) 33 (39%) 
     Paragard 7 (11%) 33 (39%) 
     Liletta 16 (25%) 12 (14%) 
     Kyleena 6 (10%) 4 (05%) 
    Skyla 3 (05%) 2 (02%) 
   
Abnormal Ultrasound 12 (19%) 23 (27%) 
   
Uterine anomaly   
     Arcuate uterus 1 (1.5%) 1 (1.2%) 
     Bicornuate uterus —— 2 (2.4%) 
   
IUD removed due to ultrasound findings 12 (19%) 23 (18%) 
 
Discussion 
Of the one hundred and forty-seven 
patients in this study, twenty-seven 
(18%) required IUD removal based on 
an IUD post insertion ultrasound. 
Additionally, of the asymptomatic group, 
fifteen (18%) required removal of the 
IUD on identified ultrasound findings at 
the 4-8 weeks IUD post insertion visit. 
Malpositioned or displaced IUD’s that 
necessitated removal in both 
symptomatic and asymptomatic patients 
were present across all ages, parity, 
postpartum insertions, and IUD brand 
types. This emphasizes the clinical 
usefulness in performing a routine 
ultrasound in all IUD post insertion 
patients. 
Though rare, unsuspected bicornuate or 
arcuate uterus may be identified on an 
IUD post insertion ultrasound. Patients 
should be informed of the lessened IUD 
potential for contraceptive efficacy or the 
relief of heavy menses, less so in the 
case of an arcuate uterus. 
The clinical significance of an 
embedded IUD arm into the 
myometrium or an IUD in the lower 
uterine segment on ultrasound is 
debatable as to its clinical effectiveness 
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or the potential for migration over time 
into an appropriate intra uterine location.  
In either case, identification of these 
findings on ultrasound necessitate 
additional patient discussion, 
counseling, and follow up as to any IUD 
related symptoms from a malpositioned 
IUD, as well as the potential risks of 
pregnancy or incomplete relief of heavy 
menses.2 
Limitations of this retrospective review 
study include a relatively low number 
(n=147) of patients, various IUD brand 
types inserted, and the lack of a control 
group for patient characteristics to allow 
for full statistical comparison. Another 
limitation is the selection bias that may 
occur in the retrospective review of 
reported data. Additionally, only 2/3 
(67%) of our patients had sufficient data 
regarding an IUD post insertion 
ultrasound being performed. 
Future studies may include a 
prospective study of sufficient numbers 
that further evaluates patient 
characteristics or IUD brand types that 
contribute to abnormal findings on the 
IUD post insertion ultrasound. 
In conclusion, the data in this study 
does support the routine use of 
performing ultrasound at the IUD post 
insertion visit in both the symptomatic 
and asymptomatic patient. 
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